ATCOR Revenue
Medical Equipment Manufacturing • 
Sydney, New South Wales, Australia • 11-20 Employees
ATCOR revenue & valuation
| Annual revenue | $4,327,836 |
| Revenue per employee | $255,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $13,900,000 |
| Total funding | No funding |
Key Contact at ATCOR
Karen Lee Macdonald P.D.Cert Ptsd
Company Director; Training Programme Designer
Company overview
| Headquarters | Sydney, New South Wales, Australia |
| Phone number | +61298748761 |
| Website | |
| NAICS | 3391 |
| SIC | 801 |
| Employees | 11-20 |
| Socials |
ATCOR Email Formats
ATCOR uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@atcormedical.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@atcormedical.com | 50% |
{first name}.{last name} | john.doe@atcormedical.com | 50% |
About ATCOR
ATCOR develops innovative medical devices and digital solutions that help identify and reduce the risk of hypertension, cardiovascular disease (CVD), and other related vascular disorders. Early detection with SphygmoCor® technology allows clinicians to detect target organ damage and manage cardiovascular disease, Alzheimer’s, kidney failure, and other vascular diseases. Using SphygmoCor® technology, researchers and clinicians are able to collect and assess clinically relevant digital vascular biomarkers to facilitate routine patient monitoring. These measurements shed insight into subclinical changes in the arterial system that demonstrate the efficacy of clinical trial therapies for chronic vascular diseases. Digital vascular biomarkers provide better prognostic and diagnostic information to target interventions—complementary and additive to—standard brachial blood pressure measurements. For over twenty years, major medical and research institutions have been using SphygmoCor® systems to improve therapeutics and treatment strategies for the world’s most devastating chronic diseases. Leading pharmaceutical companies utilize ATCOR devices to collect primary, secondary, and safety endpoint data across all phases of global clinical trials. Playing an integral role in over 4000+ studies to date, our technology has been referenced in over 7000 citations in leading medical journals. ATCOR is a subsidiary of the Australian listed company Cardiex Limited (ASX:CDX) www.cardiex.com
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
ATCOR has 8 employees across 6 departments.
Departments
Number of employees
Funding Data
ATCOR has never raised funding before.
ATCOR Tech Stack
Discover the technologies and tools that power ATCOR's digital infrastructure, from frameworks to analytics platforms.
Security
Security
JavaScript libraries
JavaScript libraries
JavaScript libraries
Maps
Miscellaneous
CDN
JavaScript libraries
WordPress themes
SEO
Italy
United Arab Emirates
United States
Frequently asked questions
4.8
40,000 users
